Your search returned 6 results.

Results
	1.	Metabolism of antisense oligonucleotides in rat liver homogenates. [electronic resource] by Crooke, R M Graham, M J Martin, M J Lemonidis, K M Wyrzykiewiecz, T Cummins, L L Producer: 20000127 In: The Journal of pharmacology and experimental therapeutics vol. 292 Availability: No items available. Save to lists Add to cart (remove)
	2.	Kinetic characteristics of Escherichia coli RNase H1: cleavage of various antisense oligonucleotide-RNA duplexes. [electronic resource] by Crooke, S T Lemonidis, K M Neilson, L Griffey, R Lesnik, E A Monia, B P Producer: 19960125 In: The Biochemical journal vol. 312 ( Pt 2) Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Hepatic distribution of a phosphorothioate oligodeoxynucleotide within rodents following intravenous administration. [electronic resource] by Graham, M J Crooke, S T Lemonidis, K M Gaus, H J Templin, M V Crooke, R M Producer: 20010719 In: Biochemical pharmacology vol. 62 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Phosphorothioate oligodeoxynucleotides distribute similarly in class A scavenger receptor knockout and wild-type mice. [electronic resource] by Butler, M Crooke, R M Graham, M J Lemonidis, K M Lougheed, M Murray, S F Witchell, D Steinbrecher, U Bennett, C F Producer: 20000222 In: The Journal of pharmacology and experimental therapeutics vol. 292 Availability: No items available. Save to lists Add to cart (remove)
	5.	In vivo distribution and metabolism of a phosphorothioate oligonucleotide within rat liver after intravenous administration. [electronic resource] by Graham, M J Crooke, S T Monteith, D K Cooper, S R Lemonidis, K M Stecker, K K Martin, M J Crooke, R M Producer: 19980803 In: The Journal of pharmacology and experimental therapeutics vol. 286 Availability: No items available. Save to lists Add to cart (remove)
	6.	Selective killing of cancer cells based on loss of heterozygosity and normal variation in the human genome: a new paradigm for anticancer drug therapy. [electronic resource] by Basilion, J P Schievella, A R Burns, E Rioux, P Olson, J C Monia, B P Lemonidis, K M Stanton, V P Housman, D E Producer: 19990819 In: Molecular pharmacology vol. 56 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)